Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Siegfried
Siegfried
Activities:
Manufacturing
Ingredients
Regulatory
Research & Development
Cleaning
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
Swiss biomanufacturing sector continues to thrive in 2023
Seigfried, Lonza, ten23 health, Bachem and Dottikon all announce major expansions
Manufacturing
DiNAQOR agrees acquisition to commercialise CGT development and manufacturing platform
Siegfried has made a total investment for the majority acquisition of CDMO DiNAMIQS and the establishment of the new GMP facility that will be in the mid-double-digit millions Swiss Francs
You need to be a subscriber to read this article.
Click here
to find out more.
Manufacturing
Optimising scale-up with flow process technologies
Speed of synthesis is of the essence when medicinal chemists invent new molecules, reports Sarah Houlton
Design & Build
Siegfried acquires three BASF sites
Acquisition represents the final step in Siegfried’s targeted 5-year procurement policy
Media
Siegfried Group sells biologics division
<p>The Siegfried Group, based in Zofingen in Switzerland, is selling its biotechnology business unit to an Indian company, Avesta Biotherapeutics and Research (ABRPL), for an undisclosed sum. </p>
Sharp increase in profits at Siegfried Group
Swiss pharmaceutical company The Siegfried Group has reported its best financial results in its 130-year history.
Subscribe now